Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Ferraro-Peyret

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Bio-Protocol|February 21, 2024
SUrface SEnsing of Translation (SUnSET), a Method Based on Western Blot Assessing Protein Synthesis Rates in vitroMarie Piecyk, Joëlle Fauvre, Cédric Duret, et al.
The FEBS Journal|June 16, 2024
Novel insights into the GCN2 pathway and its targeting. Therapeutic value in cancer and lessons from lung fibrosis developmentMarie Piecyk, Carole Ferraro-Peyret, David Laville, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytesCarole Ferraro-Peyret, Laurence Quemeneur, Monique Flacher, et al.
Arthritis Research & Therapy|November 13, 2004
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective studyCarole Ferraro-Peyret, Fabienne Coury, Jacques G Tebib, et al.
Endocrine-Related Cancer|February 12, 2009
Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological featuresStéphanie Durand, Carole Ferraro-Peyret, Mireille Joufre, et al.
Cancers|June 10, 2022
The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It ComplicatedRoumaïssa Gouasmi, Carole Ferraro-Peyret, Stéphane Nancey, et al.
Frontiers in Oncology|September 21, 2017
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell MarkersEuphemia Y Leung, Marjan E Askarian-Amiri, Debina Sarkar, et al.
European Journal of Dermatology : EJD|January 15, 2004
Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expressionLaurence Quéméneur, Marie-Cécile Michallet, Carole Ferraro-Peyret, et al.
Journal of Bone Oncology|January 21, 2020
Rapid detection of <i>EGFR</i> mutations in decalcified lung cancer bone metastasisAntoine Boureille, Carole Ferraro-Peyret, Guillaume Pontarollo, et al.
Cancers|March 4, 2020
ATF4-Dependent <i>NRF2</i> Transcriptional Regulation Promotes Antioxidant Protection during Endoplasmic Reticulum StressCarmen Sarcinelli, Helena Dragic, Marie Piecyk, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Bio-Protocol|February 21, 2024
SUrface SEnsing of Translation (SUnSET), a Method Based on Western Blot Assessing Protein Synthesis Rates in vitroMarie Piecyk, Joëlle Fauvre, Cédric Duret, et al.
The FEBS Journal|June 16, 2024
Novel insights into the GCN2 pathway and its targeting. Therapeutic value in cancer and lessons from lung fibrosis developmentMarie Piecyk, Carole Ferraro-Peyret, David Laville, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytesCarole Ferraro-Peyret, Laurence Quemeneur, Monique Flacher, et al.
Arthritis Research & Therapy|November 13, 2004
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective studyCarole Ferraro-Peyret, Fabienne Coury, Jacques G Tebib, et al.
Endocrine-Related Cancer|February 12, 2009
Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological featuresStéphanie Durand, Carole Ferraro-Peyret, Mireille Joufre, et al.
Cancers|June 10, 2022
The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It ComplicatedRoumaïssa Gouasmi, Carole Ferraro-Peyret, Stéphane Nancey, et al.
Frontiers in Oncology|September 21, 2017
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell MarkersEuphemia Y Leung, Marjan E Askarian-Amiri, Debina Sarkar, et al.
European Journal of Dermatology : EJD|January 15, 2004
Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expressionLaurence Quéméneur, Marie-Cécile Michallet, Carole Ferraro-Peyret, et al.
Journal of Bone Oncology|January 21, 2020
Rapid detection of <i>EGFR</i> mutations in decalcified lung cancer bone metastasisAntoine Boureille, Carole Ferraro-Peyret, Guillaume Pontarollo, et al.
Cancers|March 4, 2020
ATF4-Dependent <i>NRF2</i> Transcriptional Regulation Promotes Antioxidant Protection during Endoplasmic Reticulum StressCarmen Sarcinelli, Helena Dragic, Marie Piecyk, et al.
Pageof 3